Previous 10 | Next 10 |
2024-01-16 03:58:00 ET Summary In December 2023, we received $6,884.70 in dividend income. The majority of our dividend income this month came from funds. Johnson & Johnson, Target, and T. Rowe Price were clearly the top 3 individual stock payers. December is alw...
2024-01-14 08:04:48 ET Summary Viatris stock has been on the rise, up over 20% in the past month, reaching its highest price since February 2023. The company's revenues are derived from established brands, generics, and complex generics, with a significant portion coming from pate...
2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...
2024-01-12 01:06:36 ET Summary Invesco S&P 500 Pure Value ETF holds large cap value stocks with little or no growth characteristics. It is well-diversified across holdings, but overweight in the financial sector. Valuation metrics look attractive, but RPV has lagged the S&...
2024-01-10 18:50:01 ET Viatris Inc. (VTRS) J.P. Morgan 42nd Annual Healthcare Conference January 10, 2024 01:30 PM ET Company Participants Scott A. Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Chris Schott - J....
2024-01-10 15:35:59 ET More on Viatris Viatris Stock Is Dirt Cheap And Worth Buying Viatris: It Is Always Cheap, Yet It Is Always Declining Viatris Inc. 2023 Q3 - Results - Earnings Call Presentation Regeneron gains after mixed ruling in patent suit over Eyle...
2024-01-09 03:16:00 ET Summary In December, we (my wife and I) received a dividend income total of $10,193.04. Crossed the $10k threshold, again. Vanguard’s High Dividend Yield ETF, which we have been buying for 3.5 years, literally has paid immense dividends. In total,...
2024-01-07 12:00:45 ET More on AbbVie, Bristol-Myers, etc. AbbVie: Still Expensive Despite The Great M&A Acumen Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Health...
2024-01-03 07:00:00 ET Summary WisdomTree U.S. MidCap Dividend Fund ETF holds over 300 stocks weighted based on paid dividends, which favors larger companies among mid-caps. It is well-diversified across holdings but quite heavy in financials. The DON ETF is cheaper than the S...
2023-12-29 11:05:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture PR Newswire Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities a...